National Bank of Canada’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
National Bank of Canada's BNTX Position: Q1 2026 in Review
National Bank of Canada increased its BioNTech (BNTX) stake by 20% in Q1 2026, buying an estimated $9.87K and bringing the position to 580 shares worth $51.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1973.
National Bank of Canada first reported a position in BNTX in Q4 2021 and has held it in 15 quarters since. The position peaked at $5.96M in Q1 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.
- National Bank of Canada held 580 shares of BioNTech worth $51.6K as of Q1 2026.
- National Bank of Canada bought 96 BioNTech shares in Q1 2026, an estimated $9.87K.
- BioNTech made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #1973 holding.
- National Bank of Canada first reported a position in BioNTech in Q4 2021 and has held it in 15 quarters since.
- National Bank of Canada's BioNTech position peaked at $5.96M in Q1 2024.
- 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.
Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.